Core Viewpoint - Pomegranate Cloud Medical (POM.US) experienced a significant increase of nearly 16%, reaching $4.67, highlighting investor interest in the company’s growth potential in the chronic disease management sector [1] Company Overview - Pomegranate Cloud Medical was established in 2010 and operates multiple business segments including offline pharmacies, pharmaceutical e-commerce, medical delivery, and internet healthcare [1] - The company is recognized as the largest chronic disease follow-up service platform in China [1] Market Position - According to Frost & Sullivan, Pomegranate Cloud Medical ranked sixth in China's internet hospital market by the number of contracted doctors in 2022 [1] - The company has a nationwide business coverage, with over 214,200 contracted doctors and 699,300 patients as of December 31, 2024 [1] Service Metrics - Pomegranate Cloud Medical has issued approximately 3.13 million prescriptions through its contracted doctors [1] - The company leverages proprietary technology and service models to enhance chronic disease management and digitize the pharmaceutical supply chain [1] - Tools such as the "Pomegranate Doctor" management portal and WeChat public accounts facilitate a high volume of online consultations and prescription renewals [1]

Core Viewpoint - Pomegranate Cloud Medical (POM.US) experienced a significant increase of nearly 16%, reaching $4.67, highlighting its strong market position in chronic disease management services in China [1] Company Overview - Established in 2010, Pomegranate Cloud Medical operates multiple business segments including offline pharmacies, pharmaceutical e-commerce, medical distribution, and internet healthcare [1] - The company is recognized as the largest chronic disease follow-up platform in China [1] Market Position - According to Frost & Sullivan, Pomegranate Cloud Medical ranked sixth in the Chinese internet hospital market by the number of contracted doctors in 2022 [1] - As of December 31, 2024, the company has signed over 214,200 doctors and served approximately 699,300 patients [1] Service Metrics - The contracted doctors have issued around 3.13 million prescriptions, showcasing the company's extensive engagement in chronic disease management [1] - The company leverages proprietary technology and service models to enhance the digitalization of chronic disease management and pharmaceutical supply chains [1] - Tools such as the "Pomegranate Doctor" management portal and WeChat public accounts facilitate a high volume of online consultations and prescription renewals [1]